Figures & data
Figure 1 Representative samples of immunohistochemical staining of nucleus (A) weak staining; (B) strong staining) and cytoplasm (C) weak staining; (D) strong staining).
![Figure 1 Representative samples of immunohistochemical staining of nucleus (A) weak staining; (B) strong staining) and cytoplasm (C) weak staining; (D) strong staining).](/cms/asset/a113b03b-30b5-4e08-b19e-16680aacb1e6/dijg_a_12168989_f0001_c.jpg)
Table 1 Detailed MAPK10 Genetic Mutation Rates in Different Cancers (HCC, Colorectal Cancer, Stomach Cancer, and Pancreatic Cancer) and Age Groups
Figure 2 Survival curves of HCC patients based on MAPK10 and NRF2 expression levels. (A) long-term overall survival curves of high and low MAPK10 expression groups. (B) long-term disease-free survival curves of high and low MAPK10 expression groups. (C) short-term overall survival curves of high and low NRF2 expression groups. (D) short-term disease-free survival curves of high and low NRF2 expression groups. (E) long-term overall survival curves of high and low MAPK10 and NRF2 expression groups.
![Figure 2 Survival curves of HCC patients based on MAPK10 and NRF2 expression levels. (A) long-term overall survival curves of high and low MAPK10 expression groups. (B) long-term disease-free survival curves of high and low MAPK10 expression groups. (C) short-term overall survival curves of high and low NRF2 expression groups. (D) short-term disease-free survival curves of high and low NRF2 expression groups. (E) long-term overall survival curves of high and low MAPK10 and NRF2 expression groups.](/cms/asset/60bc1211-d844-4557-9b52-73fef658cb66/dijg_a_12168989_f0002_c.jpg)
Table 2 Clinical Characteristics of MAPK10 Protein Expression Groups (181 Patients)
Table 3 Clinical Characteristics of NRF2 Protein Expression Groups (181 Patients)